Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.

Cheng Y, Mansfield KJ, Allen W, Millard RJ, Burcher E, Moore KH.

Neurourol Urodyn. 2013 Sep;32(7):969-73. doi: 10.1002/nau.22344. Epub 2012 Nov 5.

PMID:
23129360
2.

Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.

Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E.

J Pharmacol Exp Ther. 2009 Mar;328(3):893-9. doi: 10.1124/jpet.108.145508. Epub 2008 Nov 24.

PMID:
19029429
3.

Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study.

Hill S, Elhilali M, Millard RJ, Dwyer PL, Lheritier K, Kawakami FT, Steel M.

Curr Med Res Opin. 2007 Nov;23(11):2697-704.

PMID:
17892634
4.
5.

Age-related changes of P2X(1) receptor mRNA in the bladder detrusor from men with and without bladder outlet obstruction.

Chua WC, Liu L, Mansfield KJ, Vaux KJ, Moore KH, Millard RJ, Burcher E.

Exp Gerontol. 2007 Jul;42(7):686-92. Epub 2007 Feb 20.

PMID:
17399929
6.

The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.

Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E.

Neurourol Urodyn. 2007;26(3):433-8; discussion 439; discussion 451-3.

PMID:
17016800
7.

Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis.

Millard RJ, Halaska M.

Curr Med Res Opin. 2006 Jan;22(1):41-8.

PMID:
16393429
8.

Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E.

Br J Pharmacol. 2005 Apr;144(8):1089-99.

9.

Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC; Duloxetine UI Study Group.

BJU Int. 2004 Feb;93(3):311-8.

10.

Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen.

Millard RJ; Asia Pacific Tolterodine Study Group.

Neurourol Urodyn. 2004;23(1):48-53.

PMID:
14694457
11.
12.

Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.

Burcher E, Zeng XP, Strigas J, Shang F, Millard RJ, Moore KH.

J Urol. 2000 Jan;163(1):331-7.

PMID:
10604385
13.

The aging bladder: morphology and urodynamics.

Elbadawi A, Diokno AC, Millard RJ.

World J Urol. 1998;16 Suppl 1:S10-34. Review. No abstract available.

PMID:
9775413
14.

Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study.

de la Rosette JJ, Witjes WP, Schäfer W, Abrams P, Donovan JL, Peters TJ, Millard RJ, Frimodt-Møller C, Kalomiris P.

Neurourol Urodyn. 1998;17(2):99-108.

PMID:
9514142
15.

Early clinical experience with continent urinary diversion.

Millard RJ, Wang Y.

Aust N Z J Surg. 1996 Dec;66(12):826-9.

PMID:
8996064
16.
17.

Urinary incontinence: the Cinderella subject.

Millard RJ, Moore KH.

Med J Aust. 1996 Aug 5;165(3):124-5. No abstract available.

PMID:
8709870
18.

Risks of self-injection therapy for impotence.

Millard RJ, Stricker PD, Lynch WJ, Dean TE, Murnaghan GF, Breslin FH.

Med J Aust. 1996 Jul 15;165(2):117-8. No abstract available.

PMID:
8692055
19.

A study of the efficacy and safety of transurethral needle ablation (TUNA) treatment for benign prostatic hyperplasia.

Millard RJ, Harewood LM, Tamaddon K.

Neurourol Urodyn. 1996;15(6):619-28; discussion 628-9.

PMID:
8916114
20.

The accuracy of portable ultrasound scanning in the measurement of residual urine volume.

Coombes GM, Millard RJ.

J Urol. 1994 Dec;152(6 Pt 1):2083-5.

PMID:
7966680
21.
22.

Bladder cancer in patients on low-dose methotrexate and corticosteroids.

Millard RJ, McCredie S.

Lancet. 1994 May 14;343(8907):1222-3. No abstract available.

PMID:
7909881
23.

The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia.

Mameghan H, Fisher RJ, Watt WH, Meagher MJ, Rosen IM, Mameghan J, Brook S, Tynan AP, Korbel EI, Millard RJ, et al.

Cancer. 1992 Jun 1;69(11):2771-8.

PMID:
1571908
24.

Management of incontinence: a urological approach.

Millard RJ.

Aust Fam Physician. 1989 Aug;18(8):958-63. Review.

PMID:
2673172
25.

The accuracy of a catheterized residual urine.

Stoller ML, Millard RJ.

J Urol. 1989 Jan;141(1):15-6.

PMID:
2908944
26.

Management of refractory detrusor instability by transvesical phenol injection.

Cameron-Strange A, Millard RJ.

Br J Urol. 1988 Oct;62(4):323-5.

PMID:
3191356
27.

Management of urinary retention.

Millard RJ.

Aust Fam Physician. 1986 Dec;15(12):1560-1, 1563. No abstract available.

PMID:
3800773
28.

Predictors of long term outcome following a bladder re-training programme.

Oldenburg B, Millard RJ.

J Psychosom Res. 1986;30(6):691-8.

PMID:
3806450
29.

Urodynamic evaluation of bladder neck obstruction in chronic prostatitis.

Murnaghan GF, Millard RJ.

Br J Urol. 1984 Dec;56(6):713-6.

PMID:
6534495
30.

The clinical significance of bladder speed.

Millard RJ.

Br J Urol. 1984 Apr;56(2):165-71.

PMID:
6208960
31.

The symptomatic, urodynamic and psychodynamic results of bladder re-education programs.

Millard RJ, Oldenburg BF.

J Urol. 1983 Oct;130(4):715-9.

PMID:
6887404
32.

Divergent perspectives in abortion counseling.

Gibb GD, Millard RJ.

Psychol Rep. 1982 Jun;50(3 Pt 1):819-22.

PMID:
7111548
33.
34.

Busulfan-induced hemorrhagic cystitis.

Millard RJ.

Urology. 1981 Aug;18(2):143-4.

PMID:
7269015
35.

Research on repeated abortion: state of the field: 1973-1979.

Gibb GD, Millard RJ.

Psychol Rep. 1981 Apr;48(2):415-24. No abstract available.

PMID:
7291383
36.
37.

Controlled clinical trial comparing intra-incisional cephaloridine and Polybactrin Spray.

Gow NM, Millard RJ, Croft RJ, Dash CH.

Chemotherapy. 1980;26(1):64-71.

PMID:
6243531
38.

Experimental neurogenic disorders of the bladder after section of cauda equina.

Murnaghan GF, Gowland SP, Rose M, Millard RJ, Stening WA.

Br J Urol. 1979 Dec;51(6):518-23.

PMID:
119563
39.

Busulphan haemorrhagic cystitis.

Millard RJ.

Br J Urol. 1978 May;50(3):210. No abstract available.

PMID:
288495
40.

How much intravenous fluid does the patient get?

Millard RJ.

Lancet. 1977 Sep 24;2(8039):665-6. No abstract available.

PMID:
71485
41.

Antimicrobial prophylaxis at laparotomy.

Menzies-Gow N, Millard RJ, Dash CH.

Lancet. 1977 Jul 23;2(8030):196. No abstract available.

PMID:
69810
42.

Nitrofurantoin lung.

Ngan H, Millard RJ, Lant AF, Trapnell DH.

Br J Radiol. 1971 Jan;44(517):21-3. No abstract available.

PMID:
5539397

Supplemental Content

Loading ...
Support Center